Aurobindo recalls hypertensive drug in US citing cancer risk
ScieGen Pharmaceuticals has initiated recall of the finished Irbesartan drug from the market, a separate notification by the FDA said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news